These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 17787045

  • 1. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
    Saiki O, Takao R, Naruse Y, Kuhara M, Imai S, Uda H.
    J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
    [Abstract] [Full Text] [Related]

  • 2. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P, Nzeusseu Toukap A, Lauwerys BR, Manicourt DH, Verschueren P, Westhovens R, Devogelaer JP, Houssiau FA.
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [Abstract] [Full Text] [Related]

  • 3. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A, Inaba M, Furumitsu Y, Okamoto K, Yukioka K, Goto H, Nishizawa Y.
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [Abstract] [Full Text] [Related]

  • 4. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA.
    J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
    [Abstract] [Full Text] [Related]

  • 5. IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    Visvanathan S, Wagner C, Smolen J, St Clair EW, Hegedus R, Baker D, Keenan G.
    Arthritis Rheum; 2006 Sep; 54(9):2840-4. PubMed ID: 16948115
    [Abstract] [Full Text] [Related]

  • 6. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT.
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy and safety of infliximab in patients with rheumatoid arthritis].
    Zhang W, Shi Q, Wu DH, Bao CD, Yang NP, Li ZG, Zhu P, Zhang X, Huang CB, He DY, Ye ZZ, Tao Y, Fang YF, Gu JR, Wu HX, Sun LY, Yang XY, Huang F, Xu HJ, Zhao DB, Zhang MJ, Zheng Y, Ai MX, Lu J, Zhang FC.
    Zhonghua Yi Xue Za Zhi; 2009 Jul 21; 89(27):1876-80. PubMed ID: 19953907
    [Abstract] [Full Text] [Related]

  • 8. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA, Neovius M, Nilsson JÅ, Petersson IF, Bratt J, van Vollenhoven RF, Ernestam S, Geborek P.
    Ann Rheum Dis; 2013 Dec 21; 72(12):1927-33. PubMed ID: 23196701
    [Abstract] [Full Text] [Related]

  • 9. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
    Tam LS, Shang Q, Li EK, Wang S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.
    J Rheumatol; 2012 Dec 21; 39(12):2267-75. PubMed ID: 22984272
    [Abstract] [Full Text] [Related]

  • 10. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
    Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO, Bathon J.
    Semin Arthritis Rheum; 2009 Oct 21; 39(2):123-31. PubMed ID: 18823645
    [Abstract] [Full Text] [Related]

  • 11. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC, Saxne T, Sjöholm A, Truedsson L, Jönsson G, Geborek P.
    Rheumatology (Oxford); 2006 Jan 21; 45(1):106-11. PubMed ID: 16287919
    [Abstract] [Full Text] [Related]

  • 12. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR, Engstrand S, Berglin E, Johnson O.
    Scand J Rheumatol; 2006 Jan 21; 35(2):107-11. PubMed ID: 16641043
    [Abstract] [Full Text] [Related]

  • 13. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):1004-7. PubMed ID: 12635469
    [Abstract] [Full Text] [Related]

  • 14. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.
    Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.
    Rheumatology (Oxford); 2007 Apr 30; 46(4):608-11. PubMed ID: 17114801
    [Abstract] [Full Text] [Related]

  • 15. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F, Michaud K.
    Arthritis Rheum; 2007 May 30; 56(5):1433-9. PubMed ID: 17469100
    [Abstract] [Full Text] [Related]

  • 16. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B, Paolino S, Sulli A, Fasciolo D, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun 30; 1069():414-9. PubMed ID: 16855168
    [Abstract] [Full Text] [Related]

  • 17. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
    Bendtzen K, Geborek P, Svenson M, Larsson L, Kapetanovic MC, Saxne T.
    Arthritis Rheum; 2006 Dec 30; 54(12):3782-9. PubMed ID: 17133559
    [Abstract] [Full Text] [Related]

  • 18. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.
    Ann N Y Acad Sci; 2006 Jun 30; 1069():420-7. PubMed ID: 16855169
    [Abstract] [Full Text] [Related]

  • 19. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
    Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, Ando S, Ogasawara M, Aburatani H, Kameda H, Amano K, Abe T, Ito S, Takeuchi T.
    Rheumatology (Oxford); 2008 Jun 30; 47(6):780-8. PubMed ID: 18388148
    [Abstract] [Full Text] [Related]

  • 20. Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis.
    Matsuno H, Yoshida K, Ochiai A, Okamoto M.
    J Rheumatol; 2007 Dec 30; 34(12):2326-33. PubMed ID: 18050387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.